Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
36.7M
-
Shares change
-
+2.16M
-
Total reported value, excl. options
-
$194M
-
Value change
-
+$9.8M
-
Put/Call ratio
-
0.27
-
Number of buys
-
60
-
Number of sells
-
-44
-
Price
-
$5.30
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q2 2018
128 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q2 2018.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.7M shares
.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (4M shares), RENAISSANCE TECHNOLOGIES LLC (3.39M shares), BlackRock Inc. (3.31M shares), JPMORGAN CHASE & CO (2.55M shares), VANGUARD GROUP INC (2.2M shares), CITADEL ADVISORS LLC (2.05M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.99M shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (1.66M shares), DIMENSIONAL FUND ADVISORS LP (1.61M shares), and ALKEON CAPITAL MANAGEMENT LLC (1.57M shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.